How many institutional investors hold BCTX?

1 tracked institutional investor disclosed a position in BCTX (BRIACELL THERAPEUTICS CORP) in their most recent 13F filing.

Who is the largest institutional holder of BCTX?

Ken Griffin, Citadel Advisors, holds the largest disclosed position in BCTX, valued at $121,605.

Where does this BCTX ownership data come from?

SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.

BCTX — BRIACELL THERAPEUTICS CORP

Name: BRIACELL THERAPEUTICS CORP (BCTX) — Institutional Ownership
Creator: InvestorLens
License: https://www.sec.gov/about/website-policies

Public company

For educational research only.InvestorLens analyzes public regulatory filings (SEC EDGAR, STOCK Act PTRs) that may be delayed by 45 days or more. Information shown is historical and is not financial, legal, or tax advice, nor a recommendation or solicitation to buy or sell any security. Always do your own research.

InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.

Sourced from SEC EDGAR public filings

About BRIACELL THERAPEUTICS CORP (BCTX)

BRIACELL THERAPEUTICS CORP (BCTX) appears in the most recent 13F filings of 1 tracked institutional investor. The largest disclosed position is held by Ken Griffin (Citadel Advisors), valued at $121,605. Across recent filings, tracked investors recorded 1 new positions, 0 increased, 0 reduced, and 0 exited. All data sourced from SEC 13F filings.

Tracked investors reporting BCTX

Investor	Firm	Shares	Market value	% of portfolio	As of
Ken Griffin	Citadel Advisors	11.1K	$121.6K	0.00%	Sep 30, 2025

Ken GriffinSep 30, 2025
Citadel Advisors
Shares
11.1K
Value
$121.6K
% Portfolio
0.00%

Recent activity

Investor	Action	Δ %	Current value	Filing date
Ken Griffin	New	—	$121.6K	Nov 14, 2025

Ken Griffin
New
$121.6KNov 14, 2025

Frequently asked questions

How many institutional investors hold BCTX?: 1 tracked institutional investor disclosed a position in BCTX (BRIACELL THERAPEUTICS CORP) in their most recent 13F filing.
Who is the largest institutional holder of BCTX?: Ken Griffin, Citadel Advisors, holds the largest disclosed position in BCTX, valued at $121,605.
Did institutional ownership of BCTX increase or decrease?: Across recent 13F filings, tracked investors recorded 1 new positions, 0 increased, 0 reduced, and 0 fully exited BCTX.
Where does this BCTX ownership data come from?: SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.